文献速递心血管胸部乳腺CT

乳腺癌放疗对心脏CT冠状动脉疾病特征的影响

Impact of Radiation Therapy for Breast Cancer on the Coronary Artery Disease Profile at Cardiac CT.
PubMed 文献 · Radiol Cardiothorac Imaging · 2026-01-01

本回顾性病例对照研究将77例接受放疗的乳腺癌患者与77例倾向性评分匹配的对照者比较,发现两组在冠状动脉钙化积分、CAD-RADS评分、阻塞性病变率及高风险斑块表型率上均无显著差异,放疗组瓣膜纤维化及纤维粘连发生率亦无显著升高。

要点

  • 乳腺癌放疗组与对照组冠状动脉钙化积分无显著差异(201.1 vs 75.4 AU,P = .64)。
  • 放疗组与对照组阻塞性病变(>50%狭窄)率无显著差异(29% vs 23%,P = .46)。
  • 放疗组左前降支或右冠状动脉与心腔纤维粘连率为对照组的1.4倍,但未达统计学显著(29% vs 13%,P = .46)。

核心结论

  • 在本病例对照人群中,乳腺癌放疗与更严重的冠状动脉狭窄、高风险斑块表型或瓣膜纤维化无关。

研究设计与样本

  • 回顾性病例对照研究,纳入154例女性患者(放疗组77例,对照组77例),按年龄、体重指数及主要心血管危险因素以P = .05水平进行倾向性评分匹配,评估冠状动脉CTA的钙化积分、CAD-RADS评分、高风险斑块表型及心外表现。

关键影像表现/征象

  • 放疗组与对照组冠状动脉钙化积分无显著差异(201.1 vs 75.4 Agatston单位,P = .64)。
  • 放疗组与对照组高风险斑块表型率无显著差异(9% vs 17%,P = .23)。
  • 放疗组与对照组瓣膜纤维化发生率低且无显著差异(5% vs 3%,P = .68)。
  • 放疗组与对照组瓣膜钙化发生率无显著差异(16% vs 9%,P = .37;OR 1.84,95%CI 0.68–5.25)。
  • 放疗组左前降支或右冠状动脉与心腔纤维粘连率为29%,对照组为13%,差异未达统计学显著(P = .46;OR 1.41,95%CI 0.68–2.97)。

诊断标准与关键数值

  • 阻塞性病变定义为狭窄>50%,放疗组29%(22/77) vs 对照组23%(18/77),P = .46,OR 1.31(95%CI 0.63–2.73)。
  • 冠状动脉狭窄严重程度以CAD-RADS评分评估,两组间无显著差异(P = .40)。
  • 左侧放疗 vs 右侧放疗的钙化积分(309 vs 120 AU,P = .23)、CAD-RADS评分(P = .43)及高风险斑块表型率(左侧11%[4/36] vs 右侧6%[2/34])均无显著差异。

临床应用与阅片要点

  • 对乳腺癌放疗后患者行冠状动脉CTA时,可同时评估冠状动脉钙化积分、CAD-RADS评分及高风险斑块表型。
  • 阅片时需注意观察瓣膜纤维化、瓣膜钙化及左前降支或右冠状动脉与心腔的纤维粘连等心外表现。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To evaluate the coronary artery disease (CAD) profile and valvular and structural alterations seen at coronary CT angiography (CTA) after radiation therapy (RT) for breast cancer in a case-control study. Materials and Methods Patients who underwent clinically indicated coronary CTA were included in this retrospective study. The following parameters were evaluated: coronary artery calcium (CAC) score, Coronary Artery Disease Reporting and Data System (CAD-RADS) score, high-risk plaque (HRP) phenotypes, and extracoronary findings (valvular fibrosis, fibrous adherence). Patients with breast cancer who underwent RT were propensity score-matched with controls (level: P = .05) for age, body mass index, and major cardiovascular risk factors to reduce selection bias and confounding. Results Among 154 female patients (mean age, 65.23 years ± 10.4 [SD]; 77 patients in RT group, 77 patients in control group), there was no evidence of a difference in CAC score between the RT and control groups (201.1 vs 75.4 Agatston units [AU], P = .64). No difference was seen in coronary stenosis severity (CAD-RADS score) (P = .40) or obstructive disease (>50% stenosis) rate (29% [22 of 77] vs 23% [18 of 77], P = .46; odds ratio [OR], 1.31 [95% CI: 0.63, 2.73]). No between-group difference was observed in high-risk plaque phenotype rate (9% [seven of 77] vs 17% [13 of 77], P = .23) or CAC or CAD-RADS scores. There was no evidence of a difference between left versus right RT for CAC (309 vs 120 AU, P = .23), coronary stenosis severity (CAD-RADS score, P = .43), or HRP phenotype rate (left, 11% [four of 36]; right, 6% [two of 34]). The prevalences of valvular fibrosis and calcifications were low (5% [four of 77] vs 3% [two of 77] [P = .68] and 16% [12 of 77] vs 9% [seven of 77] [P = .37], respectively; OR, 1.84 [95% CI: 0.68, 5.25]). The prevalence of fibrous adherence of the left anterior descending coronary artery or right coronary artery to the chambers was 1.4-fold higher in the RT group (29% [22 of 77] vs 13% [17 of 77] [P = .46]; OR, 1.41 [95% CI: 0.68, 2.97]). Conclusion RT for breast cancer was not associated with more severe coronary stenosis, HRP phenotypes, or valvular fibrosis in this case-control population cohort. Keywords: Coronary Arteries, Radiation Effects, CT-Coronary Angiography, Cardiac, Breast, Breast Cancer, Radiation Therapy, Cardiovascular Risk, Computed Tomography, Coronary Artery Disease Supplemental material is available for this article. © RSNA, 2026.

来源:Radiol Cardiothorac Imaging,查看原文。版权归原作者所有。

引用

  1. Deeg J, Swoboda M, Lacaita PG, et al. Impact of Radiation Therapy for Breast Cancer on the Coronary Artery Disease Profile at Cardiac CT. Radiol Cardiothorac Imaging. 2026. PMID: 41885623. doi:10.1148/ryct.250415

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。